跳至主要内容
临床试验/ACTRN12618002018291
ACTRN12618002018291尚未招募未知

Best pRactIce surGical and refracTive management of cataract: the BRIGhT randomised controlled trial pilot study

The George Institute for Global Health0 个研究点目标入组 40 人开始时间: 2018年12月17日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
65 Years 至 o limit(—)
性别
All

入选标准

  • Participants with bilateral cataract must be aged 65 years or older, able to walk and living in the community or self-care unit of a retirement village (aged care facility residents will be excluded).

排除标准

  • Participants will be excluded if they have a diagnosis of dementia, Parkinson’s Disease or stroke, are wheelchair bound, have significant ocular comorbidities (advanced glaucoma, retinopathy or amblyopia), are scheduled for combined ocular surgery (e.g. cataract and glaucoma), reside outside the metropolitan area, or are otherwise unable to participate in the follow-up assessments.

研究者

相似试验